PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations (PRE-SURGE 2)

NCT00958438 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

248

Enrollment

INDUSTRY

Sponsor class

Conditions

Gout

Interventions

DRUG: Placebo
DRUG: Rilonacept
DRUG: Rilonacept

Sponsor

Regeneron Pharmaceuticals